Is apixaban superior to rivaroxaban in terms of safety for patients with acute venous thromboembolism?
Year: 2026
Type: article
Abstract: Adult patients with acute venous thromboembolism are likely to experience lower bleeding risks with apixaban compared to rivaroxaban, based on direct and consistent evidence.
Author: Tripdatabase
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236151550
